Form Health is a direct-to-consumer GLP-1 telehealth platform offering semaglutide and tirzepatide with provider oversight.

An independent editorial review of Agile Health that starts from the criteria that actually matter for trust: state-licensed clinicians, the 503A compounding pathway, real clinical oversight, and pricing transparency. It also covers the pathway-level genetic context that no telehealth review score can capture before you commit.

Felix Health operates a telehealth model for GLP-1 prescriptions with flat monthly pricing. This review evaluates their business structure, clinical oversight, and how their approach compares to compounded GLP-1 options available through licensed 503A pharmacies.

Felix Health operates as a licensed telehealth platform connecting patients with providers for GLP-1 medications. Legitimacy depends on verifying state licensure, pharmacy partnerships, and clinical protocols.

TRT Nation Review is a testosterone replacement therapy platform that has expanded into GLP-1 compounded peptide offerings.

Shed Price provides telehealth GLP-1 prescriptions with transparent pricing models. Understanding how Shed Price compares to compounded options—and how individual genetic factors influence medication efficacy—can help patients make cost-effective, personalized treatment decisions.

Shed GLP-1 is a telehealth platform offering GLP-1 medications alongside lifestyle support. Clinical evidence supports GLP-1 efficacy for weight management and metabolic health, while genetic factors and biomarkers may help providers tailor treatment selection and dosing for individual patients.

Shed Cost is a telehealth platform focused on transparent GLP-1 medication pricing and accessibility. Understanding your genetic predispositions in peptide pathways can help inform treatment selection and cost considerations with your provider.

Ro is a direct-to-consumer telehealth platform offering GLP-1 medications for weight management and diabetes. This review examines Ro's clinical approach, pricing structure, and how genetic insights into peptide pathways may inform more personalized GLP-1 decisions across telehealth providers.

PlushCare is a telemedicine platform offering remote GLP-1 prescriptions through licensed physicians. This review examines PlushCare's model, costs, and clinical workflows compared to precision-based compounding approaches that incorporate genetic and metabolic context.

Orderly Meds Reviews is a comparison platform for compounded GLP-1 providers. This guide explains how to assess pharmacy quality, verify licensing, and understand the clinical differences between reputable compounding services and cost-cutting alternatives.

Orderly Meds Review is a medication management platform that helps clinicians and patients match GLP-1 therapies to individual metabolic profiles. Understanding genetic predispositions alongside clinical data can support more targeted, personalized treatment conversations.

Noom and Weightwatchers offer distinct behavioral frameworks for weight management—psychology-first vs. point-based systems—but neither replaces medical evaluation or medication therapy.

Mochi is a telehealth platform offering GLP-1 medications through remote consultations. This review evaluates Mochi's clinical approach, cost structure, and how precision-based alternatives like compounded GLP-1 with genetic assessment may support more individualized treatment planning.

LillyDirect Tirzepatide is Eli Lilly's direct-to-patient platform for brand-name tirzepatide (Mounjaro). This article explains how LillyDirect works, eligibility criteria, pricing, and how it compares to compounded tirzepatide alternatives available through licensed pharmacies.

LifeMD is a telehealth platform offering remote GLP-1 prescriptions through licensed providers. This review examines LifeMD's model, clinical approach, pricing, and how precision compounding services like PlexusDx differ in sourcing, customization, and genetic assessment capabilities.

LifeMD is a telehealth platform offering remote GLP-1 prescription services for weight loss and diabetes management. This review examines LifeMD's model, costs, clinical oversight, and how it compares to compounded GLP-1 providers like PlexusDx.

Henry Meds is a telehealth platform offering GLP-1 prescriptions through licensed providers. This review explores their clinical model, credentialing practices, and how their approach compares to direct compounding pharmacies and alternatives for personalized weight management.

Hers is a telehealth platform offering prescription GLP-1 medications for weight management through remote consultations. This review examines Hers' clinical model, costs, eligibility criteria, and how precision-based approaches like genetic assessment may complement telehealth evaluation.

Henry Meds is a telehealth platform offering GLP-1 medications through licensed pharmacies.

GoodLife Meds is a telehealth GLP-1 provider offering compounded and branded semaglutide and tirzepatide. This review examines its clinical framework, pricing, provider credentials, and how it compares to alternatives like PlexusDx that emphasize genetic testing for personalization.

GoodLife Meds Review is a telehealth GLP-1 provider offering compounded semaglutide and tirzepatide.

FuturHealth Reviews is a platform that assesses GLP-1 medication providers against clinical and safety benchmarks. Understanding its vetting criteria helps patients identify qualified practitioners offering compounded or branded GLP-1 therapies.

FuturHealth Review highlights compounded GLP-1 medications available through telehealth and in-person providers. Understanding pharmacy licensing, personalization methods, and clinical oversight helps patients make informed decisions about treatment pathways.

Fridays is a telehealth GLP-1 program dispensing compounded semaglutide and tirzepatide through licensed 503A pharmacies. This independent PlexusDx review compares its advertised month-to-month pricing, pharmacy standards, and support with the PlexusDx approach.

Eden is a telehealth platform offering GLP-1 prescription services. This guide evaluates Eden's operational model, clinical safeguards, and how to assess whether its approach aligns with your healthcare needs and medication sourcing preferences.

Direct Meds Review is a platform helping patients evaluate online GLP-1 providers by assessing credentials, safety standards, and personalization frameworks. Understanding these criteria supports informed decisions about compounded peptide options and provider selection.

Brello is a telehealth platform offering GLP-1 medications through a subscription model with tiered clinical assessments.

Mochi and Remedy Meds are telehealth platforms offering GLP-1 access through virtual consultations. Both connect patients to medications, but differ in sourcing, pricing, and clinical oversight models.

Ro and Zealthy are telehealth GLP-1 platforms serving different patient needs. Ro emphasizes broad access and brand-name medications, while Zealthy focuses on clinical personalization and compounded options.